Changes in strength, brand (manufacturer), type, origin (animal, human, human insulin analog), and/or method of manufacture may result in the need for a change in dosage.
Ukushintshwa kokuhlushwa, uhlobo (umenzi), uhlobo, imvelaphi ye-insulin (yomuntu noma i-analog ye-insulin yomuntu kanye / noma indlela yokukhiqiza kungadinga ukulungiswa kwamthamo kwe-insulin).